General Electric Medical Systems to market Surgi-Vision MRI coils:
This article was originally published in Clinica
Executive Summary
General Electric Medical Systems (GEMS) will market and distribute MRI coils from two-year-old Surgi-Vision - an emerging technology company marketing novel imaging products developed at Baltimore, Maryland-based Johns Hopkins University department of radiology. Surgi-Vision, of Columbia, Maryland, got FDA 510(k) clearance for its oesophageal and aortic coil last September. GEMS plans to market the device alongside its GE Signa MRI scanner. Later products from Surgi-Vision are planned to image the heart, urethra and prostate gland.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.